###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
ABCC6 mutations in pseudoxanthoma elasticum: an update including eight novel ones
###end article-title 0
###begin p 1
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
###xml 181 186 181 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 251 256 251 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 389 394 389 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 412 420 <span type="species:ncbi:9606">patients</span>
Pseudoxanthoma elasticum (PXE) is an autosomal recessive disorder of connective tissue, affecting the retina, the skin, and the cardiovascular system. PXE is caused by mutations in ABCC6. Up to now, the literature reports that there are 180 different ABCC6 mutations in PXE. The purpose of this paper is to report eight novel mutations in ABCC6 and to update the spectrum and frequency of ABCC6 mutations in PXE patients.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
Eye, skin, and DNA examinations were performed using standard methodologies. We newly investigated the gene in 90 probands by denaturing high-performance liquid chromatography (dHPLC) and direct sequencing. We examined a total of 166 probands.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 322 327 322 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 256 264 <span type="species:ncbi:9606">patients</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
Eight novel ABCC6 mutations (c.1685T>C, p.Met562Thr; c.2477T>C, p.Leu826Pro; c.2891G>C, p.Arg964Pro; c.3207C>A, p.Tyr1069X; c.3364delT, p.Ser1122fs; c.3717T>G, p.Tyr1293X; c.3871G>A, p.Ala1291Thr; c.4306_4312del, p.Thr1436fs) were found in seven unrelated patients. Currently, our mutation detection score is at least one ABCC6 mutation in 87% of patients with a clinical diagnosis of PXE.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
Our results support that ABCC6 is the most important, and probably the only, causative gene of PXE. In total, 188 different ABCC6 mutations have now been reported in PXE in the literature.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 968 969 968 969 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 970 971 970 971 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r2">2</xref>
###xml 301 306 <span type="species:ncbi:302767">comet</span>
###xml 363 371 <span type="species:ncbi:9606">patients</span>
###xml 718 726 <span type="species:ncbi:9606">Patients</span>
###xml 936 944 <span type="species:ncbi:9606">patients</span>
Pseudoxanthoma elasticum (PXE; OMIM ) is a heritable disorder of connective tissue, affecting the skin, retina, and blood vessels. The most frequent retinal abnormalities are peau d'orange, angioid streaks, and punched-out white chorioretinal lesions, which are visible as white dots sometimes with a comet-like tail. Angioid streaks develop in almost all of the patients and often lead to choroidal neovascularization, subretinal hemorrhages, and visual loss. Skin abnormalities usually start at the lateral sides of the neck with yellowish papules that confluence into plaques. Skin of other flexural sides of the body often follows the same course, and sometimes the skin abnormalities progress to redundant folds. Patients have an increased risk of cardiovascular complications including gastro-intestinal bleedings and arteriosclerosis. The expression of the disease is variable, and substantial clinical differences exist between patients, even within families [1,2].
###end p 11
###begin p 12
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 52 53 52 53 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r3">3</xref>
###xml 54 55 54 55 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r5">5</xref>
###xml 343 344 343 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 345 346 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
PXE is caused by mutations in a single gene, ABCC6 [3-5]. The inheritance is autosomal recessive. Recent clinical and molecular studies showed that putative dominant segregating PXE pedigrees are probably the result of mild expressions in heterozygous carriers or pseudodominance due to an unexpected high carrier frequency in the population [6-9].
###end p 12
###begin p 13
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 67 69 67 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r11">11</xref>
###xml 75 80 75 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 480 481 480 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 482 484 482 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 540 548 540 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 554 559 554 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 635 640 635 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 664 666 664 666 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r13">13</xref>
###xml 667 669 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
ABCC6 belongs to the ATP-binding cassette (ABC) gene sub-family C [10,11]. ABCC6 has 31 exons spanning about 73 kb genomic DNA. The mRNA is approximately 6 kb with an open reading frame (ORF) of 4.5 kb. The ABCC6 protein consists of 1,503 amino acids and contains 17 transmembrane-spanning domains and two intracellular nucleotide binding folds (NBFs). The NBFs consist of Walker A and B domains and a C motif critical for active ATP dependent transport across the cell membrane [1,12]. The putative ABCC6 protein structure is presented in Figure 1. Two ABCC6 pseudogenes, homologous to, respectively, the first four and nine exons of ABCC6, have been identified [13,14], complicating the mutational analysis of the gene [15].
###end p 13
###begin p 14
Schematic representation of the MRP6 protein. The protein contains 17 membrane-spanning domains and two intracellular nucleotide binding folds (NBFs). The percentages in the figure show how the mutations in our population are distributed over the different domains of the protein. The eighth cytoplasmatic loop is the most frequently mutated domain, followed by the region between the last transmembrane-spanning domain and NBF2 and by NBF2 itself. Del=deletion. In addition, 1% of the population had a deletion of the whole gene.
###end p 14
###begin p 15
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 531 533 531 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r16">16</xref>
###xml 534 536 534 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 645 647 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 648 650 648 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
ABCC6 is highly expressed in the liver and kidney. Expression in multiple other tissues including those affected by PXE (skin, retina, and vessel walls) is low or absent. The protein was localized to the basolateral membranes of both hepatocytes in the liver and the proximal kidney tubules. The natural substrate transported by the ABCC6 protein remains to be identified. Functional studies showed that ABCC6 transports glutathione S-conjugate leukotriene C(4), S-(2,4-dinitrophenyl) glutathione, and the cyclopentapeptide BQ123 [16-18]. The present view is that ABCC6 transports substrates from the liver and kidney cells back into the blood [10,18].
###end p 15
###begin p 16
###xml 38 43 38 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 206 207 206 207 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 208 210 208 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 211 213 211 213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 214 216 214 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
Up to now, 180 different mutations in ABCC6 have been reported (). Mutations were found throughout the gene, but there is a high concentration in and around the NBFs and in the eighth cytoplasmatic loop [7,9,12,19-21]. Mutation detection rates varied from 55%-97% among the different studies.
###end p 16
###begin p 17
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 124 129 124 129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
The purpose of this paper was to report eight novel mutations in ABCC6 and to update the mutation spectrum and frequency of ABCC6 mutations in PXE patients.
###end p 17
###begin title 18
Methods
###end title 18
###begin p 19
###xml 252 257 252 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 263 271 <span type="species:ncbi:9606">patients</span>
DNA of all probands/families (n=166) was collected by one of us or sent to the Netherlands Institute for Neuroscience, a referral center for geneticists and ophthalmologists from the Netherlands and other European countries, for mutational analysis of ABCC6. The patients, who had novel mutations, were clinically examined by one of us (A.P., B.C., H.K., A.M., P.dJ.) except for cases 4 and 7, and data from dermatologic, ophthalmic, and cardiovascular examinations elsewhere were collected. The dermatologic examination consisted of an inspection of the skin and histopathology of a skin biopsy. The ophthalmic examination included an assessment of visual acuity, slit-lamp examination of the anterior segment, biomicroscopy with a 90 diopter lens of the posterior pole of the eye fundus, indirect ophthalmoscopy of the peripheral retina, and digital photography of as many of the fundus signs as feasible. The cardiovascular examination included at least measurement of blood pressure, electrocardiography, and echocardiography. The clinical diagnosis of PXE was considered definite if at least two of the three following criteria were met: characteristic skin lesions at the lateral side of the neck and/or other flexural regions of the body, fragmentation and calcification of elastic fibers in a skin biopsy, and characteristic retinal lesions (peau d'orange, angioid streaks, and/or punched-out white chorioretinal lesions).
###end p 19
###begin p 20
###xml 213 215 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 517 519 517 519 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
DNA was isolated from peripheral blood by standard techniques. Polymerase chain reaction (PCR) primers, amplification conditions, and mutation analysis strategy were essentially performed as described previously [22]. After pre-screening for common mutations, all coding exons were screened by denaturing high-performance liquid chromatography (dHPLC). Exonic fragments with changed dHPLC patterns were further analyzed by direct sequencing. The known deletions of exons 23-29 and exon 15 were analyzed as described [22].
###end p 20
###begin p 21
###xml 82 84 82 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 107 112 107 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
The nomenclature for mutations was based on previously published recommendations [23] and additional . The ABCC6 cDNA consensus sequence (GenBank ) was used for DNA mutation description.
###end p 21
###begin p 22
###xml 387 512 387 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Felis catus, Gallus gallus, Monodelphis domestica, Mus musculus, Ornythorhynchus anatinus, Otolemur garnetii, Pan troglodytes</italic>
###xml 518 535 518 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Rattus norvegicus</italic>
###xml 387 398 <span type="species:ncbi:9685">Felis catus</span>
###xml 400 413 <span type="species:ncbi:9031">Gallus gallus</span>
###xml 415 436 <span type="species:ncbi:13616">Monodelphis domestica</span>
###xml 438 450 <span type="species:ncbi:10090">Mus musculus</span>
###xml 452 476 <span type="species:ncbi:9258">Ornythorhynchus anatinus</span>
###xml 497 512 <span type="species:ncbi:9598">Pan troglodytes</span>
###xml 518 535 <span type="species:ncbi:10116">Rattus norvegicus</span>
When a novel mutation was found, at least 140 control chromosomes were screened for this mutation. The controls were Caucasian individuals without any eye disease or any other apparent disorder. When the mutation was a missense mutation, conservation of the changed amino acid was checked by ClustalW multiple sequence alignment comparison for ABCC6 or other closely related proteins in Felis catus, Gallus gallus, Monodelphis domestica, Mus musculus, Ornythorhynchus anatinus, Otolemur garnetii, Pan troglodytes, and Rattus norvegicus. An amino acid was considered to be conserved when it was present in multiple proteins in these animals.
###end p 22
###begin title 23
Results
###end title 23
###begin p 24
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 369 377 369 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2</xref>
###xml 484 491 484 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 248 256 <span type="species:ncbi:9606">patients</span>
We found eight novel ABCC6 mutations (c.1685T>C, c.2477T>C, c.2891G>C, c.3207C>A, c.3364delT, c.3717T>G, c.3871G>A, and c.4306_4312del). None of these mutations were present in the control chromosomes. The eight novel mutations were found in seven patients in whom the clinical diagnosis of PXE was unambiguously established. All had characteristic skin abnormalities (Figure 2) either confirmed by a skin biopsy or in combination with characteristic ophthalmologic signs or by both (Table 1). Below, we present the molecular data in detail together with family data where relevant.
###end p 24
###begin p 25
Clinical skin features of pseudoxanthoma elasticum. Mild but characteristic skin features, consisting of papules (as indicated by an arrow) and redundant skin folds as shown on the right side of the neck of case 1. In a later stage the papules can confluence into plaques.
###end p 25
###begin title 26
###xml 52 60 <span type="species:ncbi:9606">patients</span>
Summary of the demographic and clinical data of the patients with novel mutations
###end title 26
###begin p 27
###xml 401 406 <span type="species:ncbi:302767">comet</span>
###xml 635 641 <span type="species:ncbi:9103">Turkey</span>
The diagnosis of pseudoxanthoma elasticum (PXE) can be made if a case has at least two of the following criteria: characteristic skin lesions, characteristic abnormalities in a skin biopsy, characteristic retinal lesions. Based on these criteria, all of our cases have a definite diagnosis of PXE. No genotype-phenotype correlations can be made in this small group. +=affected, as=angioid streaks, co=comet-like lesions, cv=cardiovascular, E=Spain, F=female, fam=family history, GB=Great Britain, M=male, mi=mitral valve insufficiency, n=normal, nd=not done, neg=negative, NL=Netherlands, pdo=peau d'orange, pos=positive, S=Sweden, TR=Turkey, yrs=years, ?=no information, novel mutations are bold and underlined.
###end p 27
###begin p 28
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 100 102 100 102 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
In case 1, analysis of ABCC6 revealed two mutations, the earlier reported c.3662G>A (p.Arg1221His) [24] and the novel mutation c.1685T>C (Met562Thr). This latter missense mutation changes a well conserved amino acid at the fifth extracellular loop of the protein.
###end p 28
###begin p 29
###xml 101 106 101 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 111 113 111 113 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r26">26</xref>
In case 2, we found the previously reported pathogenic sequence change, c.2787+1G>T, in intron 21 of ABCC6 [25,26] and the novel mutation, c.2477T>C (p.Leu826Pro), in exon 19. This missense mutation is located just after NBF1 and leads to the change of a well conserved amino acid.
###end p 29
###begin p 30
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
In case 3, one missense mutation was found in ABCC6, the novel mutation c.2891G>C (p.Arg964Pro), which leads to the change of a well conserved amino acid between NBF1 and NBF2. No second mutation was found.
###end p 30
###begin p 31
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
In case 4, we found a c.3207 C>A (p.Tyr1069X) nonsense mutation as well as a c.3871G>A (p.Ala1291Thr) missense mutation in ABCC6. Both mutations have not been reported before. The former mutation theoretically results in a premature chain termination and an absent or dysfunctional protein. The latter mutation changes a well conserved amino acid in NBF2.
###end p 31
###begin p 32
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 208 216 208 216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3</xref>
In case 5, two mutations were found in ABCC6, the well-known deletion of exon 23-29 and the novel mutation, c.3364delT. The angioid streaks and peau d'orange of the retina of her right eye can be observed in Figure 3. She had minimal skin abnormalities at the lateral side of her neck, just below the hair line, which were not noticed before. Her father also had a clinical diagnosis of PXE. He had peau d'orange of the retina, angioid streaks, and macular degeneration after subretinal neovascularization in both eyes. The dermatologist did not find characteristic skin lesions, but a skin biopsy from the left side of the neck showed clumping and calcification of elastic fibers. He had the exon 23-29 deletion. The mother of case 5 had the c.3364delT mutation. We did not find a second mutation in the father.
###end p 32
###begin p 33
Clinical optical features of pseudoxanthoma elasticum. 141514The retina of the right eye of case 5 shows peau d'orange (diffuse, mottled hyperpigmentation) and angioid streaks, as indicated by arrows. The angioid streaks resemble retinal blood vessels and radiate from the optic disc to the periphery of the retina. These two signs are the most frequent ophthalmologic features of pseudoxanthoma elasticum.
###end p 33
###begin p 34
###xml 46 51 46 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 154 161 <span type="species:ncbi:9606">patient</span>
Case 6 was homozygous for a novel mutation in ABCC6, c.3717T>G leading to a stop codon at position 1239 of the protein (p.Tyr1239X) just before NBF2. The patient's sister was said to be affected as well. Consanguinity between the parents was denied.
###end p 34
###begin p 35
###xml 23 28 23 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
Mutational analysis of ABCC6 in case 7 revealed the earlier reported mutation, c.4015C>T (p.Arg1339Cys) [25], and the novel mutation, c.4306_4312del. This new mutation theoretically leads to a frameshift and the introduction of a stop codon at position 1461 of the protein.
###end p 35
###begin p 36
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 715 717 715 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 718 720 718 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 234 242 <span type="species:ncbi:9606">patients</span>
###xml 264 272 <span type="species:ncbi:9606">patients</span>
###xml 648 655 <span type="species:ncbi:9606">patient</span>
In our entire data set, we found two causative ABCC6 mutations in 76 of 166 (46%) PXE probands and only a single mutation in 51 (31%) probands. In 39 (23%) probands, we did not find any mutation. PXE had been diagnosed in 19 of these patients. In the remaining 20 patients, there was either doubt about the diagnosis or not enough clinical data to prove the diagnosis. Thus at least one mutation was found in 127 (87%) of 146 probands in whom the clinical diagnosis was established a priori. This means that we found mutations in 203 (69.5%) out of 292 alleles. The type and frequencies of the different mutations found are listed in . Part of the patient and mutation data described here was published previously [19,22].
###end p 36
###begin title 37
Discussion
###end title 37
###begin p 38
###xml 667 672 667 672 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
In this study, eight novel mutations were found, which we consider to be implicated in PXE: c.1685T>C (p.Met562Thr), c.2477T>C (p.Leu826Pro), c.2891G>C (p.Arg964Pro), c.3207C>A (p.Tyr1069X), c.3364delT (p.Ser1122fs), c.3717T>G (p.Tyr1293X), c.3871G>A (p.Ala1291Thr), and c.4306_4312del (p.Thr1436fs). All of these mutations were not present in at least 140 control chromosomes, and the missense mutations lead to the change of a well conserved amino acid. This suggests that these mutations are pathogenic. Four novel mutations target the eighth cytoplasmatic loop (c.3364delT) or NBF2 (c.3717T>G, c.3871G>A, and c.4306_4312del). Both domains are known hot spots for ABCC6 mutations. Three other new mutations (c.2477T>C, c.3207C>A, and c.2891G>C) are located in between NBF1 and NBF2. The c.2477T>C mutation occurs just after NBF1 in an area targeted by three previously described mutations (c.2420G>A, c.2428G>A, and c.2458G>C). The c.3207C>A and c.2891G>C mutations target less frequently mutated domains of the ABCC6 protein. The last novel mutation, c.1685T>C, is uniquely located at the fifth extracellular loop before NBF1.
###end p 38
###begin p 39
###xml 37 42 37 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 165 173 <span type="species:ncbi:9606">patients</span>
In our entire data set, at least one ABCC6 mutation was identified in 127 (77%) of 166 probands in which there were clinical suspicions of PXE. If we exclude the 20 patients whose clinical diagnoses were questionable, we find at least one mutation in 87% of probands. We found 40 different mutations of which c.3421C>T (p.Arg1141X), c.3775delT, and a deletion of exons 23-29 were most frequent. The p.Arg1141X mutation was found in 33% of alleles with a mutation, and the latter two mutations were found in 14% and 13% of the alleles, respectively.
###end p 39
###begin p 40
We did not find any mutation in 19 of the 146 (13%) probands with a clinical diagnosis of PXE. In 51 of 146 (35%) probands, we only found one mutation. As inheritance is autosomal recessive, it is to be expected that these probands have two mutations. Taken together, our missing rate per allele is 35%, which suggests that a considerable part of the mutations in our data set could not be identified.
###end p 40
###begin p 41
###xml 103 104 103 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 148 150 148 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 171 173 171 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 26 34 <span type="species:ncbi:9606">patients</span>
Four studies in which the patients had clinically definite PXE diagnoses reported missing rates of 3% [7] or 17.1% [27] after sequencing and 12.3% [20], 14% [28], or 34% [21] after denaturing high-performance liquid chromatography (dHPLC). It is largely unclear why mutation detection rates are different in several studies. What are the possible explanations?
###end p 41
###begin title 42
###xml 26 33 <span type="species:ncbi:9606">patient</span>
Geographic differences in patient populations
###end title 42
###begin p 43
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 83 85 83 85 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 124 125 124 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 126 128 126 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 233 235 233 235 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
###xml 669 671 669 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r28">28</xref>
###xml 12 20 <span type="species:ncbi:9606">patients</span>
###xml 143 151 <span type="species:ncbi:9606">patients</span>
###xml 495 503 <span type="species:ncbi:9606">patients</span>
Most of the patients in the above mentioned studies were from Italy [27], Germany [20], France [28], and the United States [7,21]. Most of our patients were from the Netherlands. Mutation frequencies differ in different populations [12]. It is conceivable that a relatively frequent mutation in certain populations can be missed by the techniques used. Heterozygous deletions of (or part of) the gene and mutations in the promoter region and in introns can easily be missed. Thirteen French PXE patients with at least one unidentified mutation (18 unidentified alleles) after dHPLC were studied with a quantitative multiplex PCR of short fluorescent fragments (QMPSF) [28]. Five (novel) deletions were detected. This reduced the total missing rate from 14% to 10% of 130 alleles. Deletions can also be detected with multiplex ligation-dependent probe amplification (MLPA), but both QMPSF and MLPA are not yet routinely used.
###end p 43
###begin title 44
Sequencing
###end title 44
###begin p 45
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
Sequencing the gene will yield additional missense mutations, which are missed by dHPLC. This could at least partly explain the high detection rate of Miksch et al. [7].
###end p 45
###begin title 46
###xml 15 22 <span type="species:ncbi:9606">patient</span>
Differences in patient selection
###end title 46
###begin p 47
###xml 280 281 280 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 53 61 <span type="species:ncbi:9606">patients</span>
###xml 96 104 <span type="species:ncbi:9606">patients</span>
###xml 147 155 <span type="species:ncbi:9606">patients</span>
We did not have detailed clinical information of all patients and, as a result, there were some patients without a definite diagnosis of PXE. Some patients could have a PXE-like phenotype as can be seen in beta-thalassemia, sickle cell anemia, and peri-umbilical perforating PXE [1].
###end p 47
###begin title 48
Digenic inheritance
###end title 48
###begin p 49
###xml 119 124 119 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
Another, less likely, possibility is digenic inheritance in the patients without two mutations. The combination of one ABCC6 mutation with a mutation in another gene could lead to PXE. This could be different for different populations.
###end p 49
###begin p 50
###xml 63 68 63 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 363 365 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
###xml 400 405 400 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 407 415 407 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 769 771 769 771 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r12">12</xref>
Including the mutations presented here, at least 188 different ABCC6 mutations have been published to date in the international literature (). In the European populations, the p.Arg1141X mutation is by far the most prevalent (about 28% of alleles) while in the United States population, the exon 23-29 deletion occurs most frequently (also about 28% of alleles) [25,29]. The mutation distribution in ABCC6 (Figure 1) shows three mutation hot spot domains: the first and second NBF as well as the eighth cytoplasmatic loop. Indeed, the latter is truly a hot spot for mutations since the frequent mutations, p.Arg1141X and the exon 23-29 deletion, target this area. It has been suggested that the eighth cytoplasmatic loop may be involved in ABCC6 substrate recognition [12]. In our data set, mutations in these three domains were found in 71% of the alleles with mutations. Screening of the involved exons 16-18, 24, and 27-30 together with the detection of the exon 23-29 deletion would detect 95% of all of our mutations.
###end p 50
###begin p 51
###xml 93 100 93 100 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="t1">Table 1</xref>
###xml 582 584 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 690 692 690 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 804 805 804 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 806 808 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 809 811 809 811 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 812 814 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 815 817 815 817 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 911 913 911 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 914 916 914 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r27">27</xref>
###xml 917 919 917 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r31">31</xref>
###xml 14 22 <span type="species:ncbi:9606">patients</span>
###xml 724 731 <span type="species:ncbi:9606">patient</span>
In all of our patients who had novel mutations, a diagnosis of PXE could be made clinically (Table 1). The group was too small to establish genotype-phenotype correlations. In the data set, we observed considerable intra-and interfamilial variations in phenotype, and we could not extract a genotype-phenotype relationship either. Previous reports on potential genotype-phenotype correlations revealed variable results. Diagnosis at a significantly younger age and a higher number of affected organs were found in the case of mutations that lead to an absence of (functional) MRP6 [30]. It was suggested that nonsense mutations were more frequently associated with generalized involvement [27]. However, even in an extended patient series, no clear genotype-phenotype correlation could be found to date [7,19,21,25,27]. Besides, there is marked variable expression within family members with the same genotype [19,27,31].
###end p 51
###begin p 52
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
###xml 167 172 167 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
In summary, we provide further evidence that ABCC6 is the most important, and probably the only, causative gene implicated in PXE. We added eight new mutations to the ABCC6 mutation spectrum and supported the notion that most mutations are present in the cytoplasmatic domains at the carboxy terminal end of the protein, especially in the three putative important functional domains of ABCC6 (NBF1, NBF2, and the eighth cytoplasmatic loop).
###end p 52
###begin title 53
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ABCC6</italic>
Appendix 1. All ABCC6 mutations which are implicated in pseudoxanthoma elasticum
###end title 53
###begin p 54
To access the data, click or select the words "". This will initiate the download of a compressed (zip) archive that contains the file. This file should be uncompressed with an appropriate program (the particular program will depend on your operating system). We found mutations in 203 alleles. The fourth column shows the frequency of the different mutations among the alleles. Novel mutations are bold and underlined.
###end p 54
###begin p 55
References found only in Appendix:
###end p 55
###begin p 56
32. Struk B, Cai L, Zach S, Ji W, Chung J, Lumsden A, Stumm M, Huber M, Schaen L, Kim CA, Goldsmith LA, Viljoen D, Figuera LE, Fuchs W, Munier F, Ramesar R, Hohl D, Richards R, Neldner KH, Lindpaintner K. Mutations of the gene encoding the transmembrane transporter protein ABC-C6 cause pseudoxanthoma elasticum. J Mol Med 2000; 78:282-6.
###end p 56
###begin p 57
33. Yoshida S, Honda M, Yoshida A, Nakao S, Goto Y, Nakamura T, Fujisawa K, Ishibashi T. Novel mutation in ABCC6 gene in a Japanese pedigree with pseudoxanthoma elasticum and retinitis pigmentosa. Eye 2005; 19:215-7.
###end p 57
###begin p 58
34. Meloni I, Rubegni P, De Aloe G, Bruttini M, Pianigiani E, Cusano R, Seri M, Mondillo S, Federico A, Bardelli AM, Andreassi L, Fimiani M, Renieri A. Pseudoxanthoma elasticum: Point mutations in the ABCC6 gene and a large deletion including also ABCC1 and MYH11. Hum Mutat 2001; 18:85.
###end p 58
###begin p 59
35. Ringpfeil F, Nakano A, Uitto J, Pulkkinen L. Compound heterozygosity for a recurrent 16.5-kb Alu-mediated deletion mutation and single-base-pair substitutions in the ABCC6 gene results in pseudoxanthoma elasticum. Am J Hum Genet 2001; 68:642-52.
###end p 59
###begin p 60
36. Katona E, Aslanidis C, Remenyik E, Csikos M, Karpati S, Paragh G, Schmitz G. Identification of a novel deletion in the ABCC6 gene leading to Pseudoxanthoma elasticum. J Dermatol Sci 2005; 40:115-21.
###end p 60
###begin title 61
ACKNOWLEDGMENTS
###end title 61
###begin p 62
The authors thank the Algemene Nederlandse Vereniging ter Voorkoming van Blindheid for support of our Ophthalmogenetic research program.
###end p 62
###begin title 63
Reference
###end title 63
###begin article-title 64
Pseudoxanthoma elasticum: a clinical, histopathological, and molecular update.
###end article-title 64
###begin article-title 65
Pseudoxanthoma elasticum.
###end article-title 65
###begin article-title 66
Mutations in ABCC6 cause pseudoxanthoma elasticum.
###end article-title 66
###begin article-title 67
Mutations in a gene encoding an ABC transporter cause pseudoxanthoma elasticum.
###end article-title 67
###begin article-title 68
Pseudoxanthoma elasticum: mutations in the MRP6 gene encoding a transmembrane ATP-binding cassette (ABC) transporter.
###end article-title 68
###begin article-title 69
Pseudoxanthoma elasticum: the end of the autosomal dominant segregation myth.
###end article-title 69
###begin article-title 70
Molecular genetics of pseudoxanthoma elasticum: type and frequency of mutations in ABCC6.
###end article-title 70
###begin article-title 71
Does autosomal dominant pseudoxanthoma elasticum exist?
###end article-title 71
###begin article-title 72
Pseudoxanthoma elasticum is a recessive disease characterized by compound heterozygosity.
###end article-title 72
###begin article-title 73
###xml 14 19 <span type="species:ncbi:9606">human</span>
Expression of human MRP6, a homologue of the multidrug resistance protein gene MRP1, in tissues and cancer cells.
###end article-title 73
###begin article-title 74
Mammalian ABC transporters in health and disease.
###end article-title 74
###begin article-title 75
Pseudoxanthoma elasticum: a clinical, pathophysiological and genetic update including 11 novel ABCC6 mutations.
###end article-title 75
###begin article-title 76
A novel Q378X mutation exists in the transmembrane transporter protein ABCC6 and its pseudogene: implications for mutation analysis in pseudoxanthoma elasticum.
###end article-title 76
###begin article-title 77
Pseudoxanthoma elasticum: evidence for the existence of a pseudogene highly homologous to the ABCC6 gene.
###end article-title 77
###begin article-title 78
###xml 39 44 <span type="species:ncbi:9606">human</span>
Identification of ABCC6 pseudogenes on human chromosome 16p: implications for mutation detection in pseudoxanthoma elasticum.
###end article-title 78
###begin article-title 79
Characterization of the drug resistance and transport properties of multidrug resistance protein 6 (MRP6, ABCC6).
###end article-title 79
###begin article-title 80
###xml 91 96 <span type="species:ncbi:9606">human</span>
Loss of ATP-dependent transport activity in pseudoxanthoma elasticum-associated mutants of human ABCC6 (MRP6).
###end article-title 80
###begin article-title 81
###xml 62 65 <span type="species:ncbi:10116">rat</span>
Transport function and hepatocellular localization of mrp6 in rat liver.
###end article-title 81
###begin article-title 82
ABCC6/MRP6 mutations: further insight into the molecular pathology of pseudoxanthoma elasticum.
###end article-title 82
###begin article-title 83
###xml 85 93 <span type="species:ncbi:9606">patients</span>
Mutational analysis of the ABCC6 gene and the proximal ABCC6 gene promoter in German patients with pseudoxanthoma elasticum (PXE).
###end article-title 83
###begin article-title 84
Mutation detection in the ABCC6 gene and genotype-phenotype analysis in a large international case series affected by pseudoxanthoma elasticum.
###end article-title 84
###begin article-title 85
Efficient molecular diagnostic strategy for ABCC6 in pseudoxanthoma elasticum.
###end article-title 85
###begin article-title 86
Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion.
###end article-title 86
###begin article-title 87
###xml 70 73 <span type="species:ncbi:9606">boy</span>
Acute myocardial infarction and a new ABCC6 mutation in a 16-year-old boy with pseudoxanthoma elasticum.
###end article-title 87
###begin article-title 88
A spectrum of ABCC6 mutations is responsible for pseudoxanthoma elasticum.
###end article-title 88
###begin article-title 89
Molecular genetics of pseudoxanthoma elasticum: a metabolic disorder at the environment-genome interface?
###end article-title 89
###begin article-title 90
ABCC6 mutations in Italian families affected by pseudoxanthoma elasticum (PXE).
###end article-title 90
###begin article-title 91
###xml 100 108 <span type="species:ncbi:9606">patients</span>
Contribution of ABCC6 genomic rearrangements to the diagnosis of pseudoxanthoma elasticum in French patients.
###end article-title 91
###begin article-title 92
Analysis of the frequent R1141X mutation in the ABCC6 gene in pseudoxanthoma elasticum.
###end article-title 92
###begin article-title 93
###xml 44 52 <span type="species:ncbi:9606">patients</span>
Novel mutations in the ABCC6 gene of German patients with pseudoxanthoma elasticum.
###end article-title 93
###begin article-title 94
Novel ABCC6 mutations in pseudoxanthoma elasticum.
###end article-title 94

